Pharma Project II SA
Pharma Project II reported total assets of 494,924 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026).
The score of Pharma Project II shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -13 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Project II's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 26,526 € | ||||
| Equity | −222,890 € | ||||
| Cash | 7,094 € | ||||
| EBITDA | 76,950 € | ||||
| Total assets | 494,924 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 04 Jul 2024
- Year ended 31 Dec 2022filed on 29 Jun 2023
- Year ended 31 Dec 2021filed on 15 Jul 2022
Pharma Project II's financial analysis
- Solvency-45.0%sector median: 18.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Project II
Pharma Project II's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0823.439.235
- VAT number
- BE0823439235
- Peppol
- Registered · 0208:0823439235 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Feb 2010
- Registered office
- 1300 Wavre
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Buying and selling of own real estate (NACE 68110)
Pharma Project II (SA) has been based in Wavre since 2010, active in: buying and selling of own real estate. For 2025, it reports a net profit of 26,526 € and equity of −222,890 €; its revenue is not published. Its solvency stands at -45.0%, below the median of its sector (18.4%).
Companies similar to Pharma Project II
Companies in the same business, of comparable size and area, outside its group.
- LA Centrale Hypothecaire Manufacture of metal structures and parts of structures Fleurus · balance sheet 494,812 €
- Ferzo Invest Manufacture of furniture Temse · balance sheet 494,508 €
- Atys Patrimoniale Mons · balance sheet 494,624 €
- Nacamar Knokke-Heist · balance sheet 464,102 €
- Lieven Van Braeckel, psychiater Antwerp · balance sheet 494,485 €
Frequently asked questions about Pharma Project II
What is the revenue of Pharma Project II?
Pharma Project II files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Project II?
In Belgium, the VAT number is the company number prefixed with BE: BE0823439235 for Pharma Project II, if the company is VAT-registered. Its company number (CBE) is 0823.439.235.
Where is the registered office of Pharma Project II?
According to the CBE register, the registered office of Pharma Project II is in 1300 Wavre.
What is the equity of Pharma Project II?
At the close of the 2025 financial year, the equity of Pharma Project II amounts to -222,890 €, a solvency of -45.0% of total assets.
Who manages Pharma Project II?
The register lists 2 active mandates at Pharma Project II. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Project II
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →